Followers | 57 |
Posts | 11137 |
Boards Moderated | 2 |
Alias Born | 04/25/2012 |
Friday, April 28, 2017 9:18:43 AM
The correlation between La Croix revenues and $FIZZ overall revenues is strong (0.62).
The correlation between La Croix revenues and $FIZZ overall earnings is even stronger (0.72).
In 2016, La Croix sales were $16.4M in March and $19.2M in April, a 17% increase month-over-month. It's a typical seasonal spike.
If we get the same in 2017, that would mean over $30M+ in La Croix sales for April (doesn't include Curate in my opinion). Note: In 2016, Easter was in March; 2017 it was in April - favorable sign.
I think since the Glaucus report, Nick has been pushing as much La Croix out the door as humanly possible, to stick it up shorts' a$$e$. It's spiked the revenues but it's really spiked the bottom line. Said another way, the product mix features more high margin product (La Croix). The top line (round illustrative numbers) is growing at 15% but the bottom line is growing at 45%.
It's one thing to push product out the door. It's another for the public to absorb it. April LAC sales will be the DEW (distant early warning) for the late July 10K. If the April LAC sales figure starts with a "3" (i.e., $30M+), $100 per share will be in play.
The opposite side of that coin, say monthly revenues come in at ~$27M, will be a less seasonal revenue stream for La Croix in 2017, or a revenue stream with about ~$25M per month, whether it is summer or winter. This might suggest its time to take some money off the table.
Recent FIZZ News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/07/2024 09:25:15 PM
- National Beverage Corp. Reports Exceptional Winter Quarter • Business Wire • 03/07/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:46:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:45:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 09:45:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:48:46 PM
- National Beverage Commemorates 30 Years of Supporting ‘HOPE’ for the Children of St. Jude • Business Wire • 12/15/2023 03:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:48:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:32:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/07/2023 09:23:36 PM
- National Beverage Corp. Reports Record Revenues and Double-Digit Earnings Growth • Business Wire • 12/07/2023 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 09:53:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/25/2023 09:06:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 09:14:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/16/2023 07:09:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:30:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:30:15 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 09/07/2023 09:22:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/07/2023 08:31:31 PM
- National Beverage Corp. Reports Robust Earnings on Record Revenues • Business Wire • 09/07/2023 08:21:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/25/2023 09:20:04 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/11/2023 09:15:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 08:30:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/28/2023 09:05:29 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM